2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

被引：407

作者：

Vansteenkiste, J. ^{[1
]}

Crino, L. ^{[2
]}

Dooms, C. ^{[1
]}

Douillard, J. Y. ^{[3
]}

Faivre-Finn, C. ^{[4
]}

Lim, E. ^{[5
,6
]}

Rocco, G. ^{[7
]}

Senan, S. ^{[8
]}

Van Schil, P. ^{[9
]}

Veronesi, G. ^{[10
]}

Stahel, R. ^{[11
]}

Peters, S. ^{[12
]}

Felip, E. ^{[13
]}

机构：

[1] Univ Hosp KU Leuven, Resp Oncol Unit Pulmonol, Leuven, Belgium

[2] Azienda Osped Perugia, Santa Maria Della Misericordia Hosp, Dept Oncol, Perugia, Italy

[3] Integrated Ctr Oncol R Gauducheau, Dept Med Oncol, St Herblain, France

[4] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England

[5] Univ London Imperial Coll Sci Technol & Med, London, England

[6] Royal Brompton Hosp, Acad Div Thorac Surg, London SW3 6LY, England

[7] Pascale Fdn, IRCCS, Natl Canc Inst, Dept Thorac Surg & Oncol, Naples, Italy

[8] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands

[9] Univ Antwerp Hosp, Dept Thorac & Vasc Surg, Antwerp, Belgium

[10] European Inst Oncol, Dept Thorac Surg, Milan, Italy

[11] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland

[12] CHU Vaudois, Dept Oncol, CH-1011 Lausanne, Switzerland

[13] Vall DHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2014年 / 25卷 / 08期

关键词：

ESMO; consensus; lung cancer; non-small-cell lung cancer; early disease; STEREOTACTIC BODY RADIOTHERAPY; VINORELBINE PLUS CISPLATIN; ASSISTED THORACIC-SURGERY; CARDIAC RISK INDEX; ABLATIVE RADIOTHERAPY; PULMONARY NODULES; INTERNATIONAL ASSOCIATION; ADJUVANT VINORELBINE; EMISSION-TOMOGRAPHY; SUBLOBAR RESECTION;

D O I：

10.1093/annonc/mdu089

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on early-stage disease.

引用

页码：1462 / 1474

页数：13

共 50 条

[1] 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
Eberhardt, W. E. E.
De Ruysscher, D.
Weder, W.
Le Pechoux, C.
De Leyn, P.
Hoffmann, H.
Westeel, V.
Stahel, R.
Felip, E.
Peters, S.
ANNALS OF ONCOLOGY, 2015, 26 (08) : 1573 - 1588
[2] 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
Besse, B.
Adjei, A.
Baas, P.
Meldgaard, P.
Nicolson, M.
Paz-Ares, L.
Reck, M.
Smit, E. F.
Syrigos, K.
Stahel, R.
Felip, E.
Peters, S.
ANNALS OF ONCOLOGY, 2014, 25 (08) : 1475 - 1484
[3] Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Besse, B.
ANNALS OF ONCOLOGY, 2007, 18 : 30 - 31
[4] Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
D'Addario, G.
Felip, E.
ANNALS OF ONCOLOGY, 2009, 20 : 68 - 70
[5] Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
D'Addario, G.
Felip, E.
ANNALS OF ONCOLOGY, 2008, 19 : 39 - 40
[6] Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
Kerr, K. M.
Bubendorf, L.
Edelman, M. J.
Marchetti, A.
Mok, T.
Novello, S.
O'Byrne, K.
Stahel, R.
Peters, S.
Felip, E.
ANNALS OF ONCOLOGY, 2014, 25 (09) : 1681 - 1690
[7] ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Honecker, F.
Aparicio, J.
Berney, D.
Beyer, J.
Bokemeyer, C.
Cathomas, R.
Clarke, N.
Cohn-Cedermark, G.
Daugaard, G.
Dieckmann, K-P.
Fizazi, K.
Fossa, S.
Germa-Lluch, J. R.
Giannatempo, P.
Gietema, J. A.
Gillessen, S.
Haugnes, H. S.
Heidenreich, A.
Hemminki, K.
Huddart, R.
Jewett, M. A. S.
Joly, F.
Lauritsen, J.
Lorch, A.
Necchi, A.
Nicolai, N.
Oing, C.
Oldenburg, J.
Ondrus, D.
Papachristofilou, A.
Powles, T.
Sohaib, A.
Stahl, O.
Tandstad, T.
Toner, G.
Horwich, A.
ANNALS OF ONCOLOGY, 2018, 29 (08) : 1658 - 1686
[8] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)
Felip, E
ANNALS OF ONCOLOGY, 2001, 12 (08) : 1049 - 1050
[9] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)
Felip, E
Stahel, RA
Pavlidis, N
ANNALS OF ONCOLOGY, 2005, 16 : 28 - 29
[10] Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Novello, S.
Barlesi, F.
Califano, R.
Cufer, T.
Ekman, S.
Levra, M. Giaj
Kerr, K.
Popat, S.
Reck, M.
Senan, S.
Simo, G. V.
Vansteenkiste, J.
Peters, S.
ANNALS OF ONCOLOGY, 2016, 27 : v1 - v27

← 1 2 3 4 5 →